Shenghou Medical, LLC shareholders have always been comprised of Richard Blumber, who has also always been its manager, and Mark Faupel, who has always been a shareholder and at one point in time also a manager. Shenghou Medical LLC, now know as K2 had the original license with GTHP, despite having no expertise to satisfy its obligation to perform the same so it found SMI to enter into a new arrangement with GTHP. Because Shanghou Medical LLC gave up contractual rights it received a royalty interest from any monies GTHP would receive from SMI. GTHP did in fact receive monies from SMI and subsequently GTHP then did in fact paid a portion of the monies it received out to Shenghou Medical LLL now know as K2. GTHP is contractually obligate to pay Shenghou Medical, LLC now as "K2" royalty type payments on any monies GTHP receives from SMI.
I am not responsible for others failures to make required SEC disclosures.
I am a shareholder of GTHP so perhaps you are right with voicing shareholder concerns for non disclosures and any ramifications for the such non disclosures if that proves to be the case.
Bearish
News 
Market Data 
Discover 
